Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
KLAC arrives at its October 28 earnings date in a peculiar position: short interest remains elevated at 17% of float, yet the bears have been quietly retreating for a month, leaving the stock caught between receding pressure from one side and a freshly lowered price target from Morgan Stanley on the other.
The short-interest story is one of gradual unwinding rather than fresh conviction. Shorts peaked above 29 million shares in mid-September and have since fallen roughly 24%, landing at 22.4 million shares, or 17% of free float. That is still a meaningful position, but the direction has been consistently lower, down about 11% on the month and off a further 1% on the week. The borrowing market reflects the same easing. Cost to borrow has dropped sharply, falling nearly 40% week-on-week to just 0.28%, the lowest level in the 30-day window. Availability is fully loose, with more than 1.2 billion shares available to lend against the 22 million currently borrowed. There is no squeeze pressure here. The ORTEX short score of 30.4 sits in the 78th percentile of the universe by short score rank, flagging structural short interest, but with the borrow market this relaxed, that reading is about persistence, not intensity.
Options positioning tells a notably more defensive story than the lending market. The put/call ratio has pulled back to 1.28, its lowest reading in the past 30 days and below its 20-day average of 1.36, suggesting some hedging demand has eased in recent sessions. But context matters: even at 1.28, the PCR is still well above 1 and has been trending down from above 1.56 in late August, a slow drift rather than a clean shift in sentiment. The z-score of negative 1.17 means the market is slightly less defensive than its recent norm, not bullish. With the next earnings print three weeks away, the put book may rebuild.
The Street is broadly positive but flagging a ceiling. The consensus sits at buy with a mean price target of $232.77 against a current price of $197.55, implying roughly 18% upside on paper. Morgan Stanley's Shane Brett moved yesterday, maintaining Overweight but cutting the target from $253 to $227, the most recent signal that even bulls are trimming their ambitions. The post-July earnings round of cuts was severe: Wells Fargo dropped from $305 to $245, Susquehanna from $275 to $215, Deutsche Bank to $195. Only JP Morgan moved the other way, raising to $238 from $200 after that same print. The bear case rests on China exposure above 30% of revenue, export control risk, and valuation. The PE of 30.7 and EV/EBITDA of 25.6 have both compressed over the past week alongside the 4.5% single-day drop on October 6, but multiples have still expanded on the 30-day horizon. Bulls point to KLA's dominant share in process control equipment, rising complexity at TSMC and Samsung, and management's $140 billion-plus 2026 wafer fab equipment view as reasons to hold through sector volatility.
The peer group moved more cleanly this week. AMAT rose 3.6% on the week, LRCX gained 3.1%, and COHU led the group up nearly 11%. KLAC's 0.5% weekly gain leaves it a relative laggard among its closest correlates, and the 4.5% single-day pullback on October 6 stands out against AMAT's milder 2.2% decline on the same day. That gap may simply reflect the Morgan Stanley target cut landing in the market, but it is worth watching whether KLAC continues to lag equipment peers into earnings.
All eyes now move to the October 28 print. The last quarterly result produced a 16% single-day drop, the most visible data point in the recent earnings history. Short sellers are less loaded than they were a month ago, the borrow market is relaxed, and the options market has pulled back from peak defensiveness, but it has not been abandoned. Whether the Street's target reductions have adequately front-run any guidance disappointment, particularly on China and foundry demand, is the question that will dominate the run-up.
See the live data behind this article on ORTEX.
Open KLAC on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
